Rates of processing determine the immunogenicity of immunoproteasome- generated epitopes

Journal of Immunology

Volumn 178, Issue 12, 2007, Pages 7557-7562

  Deol, Parampal ^a   Zaiss, Dietmar M W ^a   Monaco, John J ^b   Sijts, Alice J A M ^b,c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; IMMUNOPROTEASOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; GENETIC STABILITY; IMMUNOGENICITY; LISTERIA MONOCYTOGENES; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VACCINE PRODUCTION;

EID: 34250167524     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.12.7557     Document Type: Article

References (24)

1. + T cell responses. Immunity 25: 533-543.
2. Yewdell, J. W., and J. R. Bennink. 1999. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17: 51-88.
3. Khan, S., M. van den Broek, K. Schwarz, R. de Giuli, P. A. Diener, and M. Groettrup. 2001. Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver. J. Immunol. 167: 6859-6868.
4. Sijts, A., D. Zaiss, and P. M. Kloetzel. 2001. The role of the ubiquitin-proteasome pathway in MHC class 1 antigen processing: implications for vaccine design. Curr. Mol. Med. 1: 665-676.
5. Kloetzel, P. M. 2001. Antigen processing by the proteasome. Nat. Rev. Mol. Cell Biol. 2: 179-187.
6. Willis, R. A., J. W. Kappler, and P. C. Marrack. 2006. CD8 T cell competition for dendritic cells in vivo is an early event in activation. Proc. Natl. Acad. Sci. USA 103: 12063-12068.
7. Sijts, A. J., S. Standera, R. F. Toes, T. Ruppert, N. J. Beekman, P. A. van Veelen, F. A. Ossendorp, C. J. M. Melief, and P. M. Kloetzel. 2000. MHC class 1 antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells. J. Immunol. 164: 4500-4506.
8. Foulds, K. E., F. A. Zenewicz, D. J. Shedlock, J. Jiang, A. E. Troy, and H. Shen. 2002. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J. Immunol. 168: 1528-1532.
9. Caudill, C. M., K. Jayarapu, L. Elenich, J. J. Monaco, R. A. Colbert, and T. A. Griffin. 2006. T cells lacking immunoproteasome subunits MECL-1 and LMP7 hyperproliferate in response to polyclonal mitogens. J. Immunol. 176: 4075-4082.
10. Zaiss, D. M., S. Standera, P. M. Kloetzel, and A. J. Sijts. 2002. PI31 is a modulator of proteasome formation and antigen processing. Proc. Natl. Acad. Sci. USA 99: 14344-14349.
11. Anton, L. C., J. W. Yewdell, and J. R. Bennink. 1997. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. J. Immunol. 158: 2535-2542.
12. Sijts, A. J., I. Pilip, and E. G. Pamer. 1997. The Listeria monocytogenes-secreted p60 protein is an N-end rule substrate in the cytosol of infected cells: implications for major histocompatibility complex class I antigen processing of bacterial proteins. J. Biol. Chem. 272: 19261-19268.
13. k mice. J. Immunol. 146: 3977-3984.
14. Toes, R. E., R. Offringa, R. J. Blom, R. M. Brandt, A. J. van der Eb, C. J. Melief, and W. M. Kast. 1995. An adenovirus lype 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogene. J. Immunol. 154: 3396-3405.
15. Niedermann, G., R. Grimm, E. Geier, M. Maurer, C., Realini, C. Gartmann, J. Soll, S. Omura, M. C. Rechsteiner, W. Baumeister, and K. Eichmann. 1997. Potential immunocompetence of proteolytic fragments produced by proteasomes before evolution of the vertebrate immune system. J. Exp. Med. 186: 209-220.
16. + T cells by exogenous cell-associated antigens. Immunity 17: 211-220.
17. Zammit, D. J., F. S. Cauley, Q. M. Pham, and L. Lefrancois. 2005. Dendritic cells maximize the memory CD8 T cell response to infection. Immunity 22: 561-570.
18. Mercado, R., S. Vijh, S. E. Allen, K. Kerksiek, I. M. Pilip, and E. G. Pamer. 2000. Early programming of T cell populations responding to bacterial infection. J. Immunol. 165: 6833-6839.
19. + T cells at the levels of T cell repertoire and presentation of viral antigens. J. Exp. Med. 193: 1319-1326.
20. + T cell priming by dendritic cells in intact lymph nodes. Nat. Immunol. 4: 579-585.
21. + T cells by infected dendritic cells in vivo. Nat. Immunol. 3: 265-271.
22. Itano, A. A., S. J. McSorley, R. F. Reinhardt, B. D. Ehst, E. Ingulli, A. Y. Rudensky, and M. K. Jenkins. 2003. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19: 47-57.
23. Steven, N. M., N. E. Annels, A. Kumar, A. M. Leese, M. G. Kurilla, L. Frappier, and A. Rickinson. 1997. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J. Exp. Med. 185: 1605-1617.
24. Probst, H. C., K. Tschannen, A. Gallimore, M. Martinic, M. Basler, T. Dumrese, E. Jones, and M. F. van den Broek. 2003. Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J. Immunol. 171: 5415-5422.